MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/23120541.00462-2021

Медицинская библиотека · ERJ open research · 2022

NSAID-exacerbated respiratory disease: a population study.

Andersén Heidi, Ilmarinen Pinja, Honkamäki Jasmin, Tuomisto Leena E, Hisinger-Mölkänen Hanna, Backman Helena, Lundbäck Bo, Rönmark Eva, Haahtela Tari, Sovijärvi Anssi, Lehtimäki Lauri, Piirilä Päivi, Kankaanranta Hannu

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Nonsteroidal anti-inflammatory drugs (NSAIDs) may exacerbate respiratory symptoms. A recent European Academy of Allergy and Clinical Immunology position paper recommended the use of an acronym, N-ERD (NSAID-exacerbated respiratory disease), for this hypersensitivity associated with asthma or chronic rhinosinusitis with or without nasal polyposis. Our aim was to estimate the prevalence of N-ERD and identify factors associated with N-ERD.

METHODS

In 2016, a cross-sectional questionnaire survey of a random adult population of 16 000 subjects aged 20-69 years was performed in Helsinki and Western Finland. The response rate was 51.5%.

RESULTS

The prevalence was 1.4% for N-ERD, and 0.7% for aspirin-exacerbated respiratory disease (AERD). The prevalence of N-ERD was 6.9% among subjects with asthma and 2.7% among subjects with rhinitis. The risk factors for N-ERD were older age, family history of asthma or allergic rhinitis, long-term smoking and exposure to environmental pollutants. Asthmatic subjects with N-ERD had a higher risk of respiratory symptoms, severe hypersensitivity reactions and hospitalisations than asthmatic subjects without N-ERD. The subphenotype of N-ERD with asthma was most symptomatic. Subjects with rhinitis associated with N-ERD, which would not be included in AERD, had the fewest symptoms.

CONCLUSION

We conclude that the prevalence of N-ERD was 1.4% in a representative Finnish adult population sample. Older age, family history of asthma or allergic rhinitis, cumulative exposure to tobacco smoke, secondhand smoke, and occupational exposures increased odds of N-ERD. N-ERD was associated with significant morbidity.

Для цитирования: Andersén Heidi, Ilmarinen Pinja, Honkamäki Jasmin, Tuomisto Leena E, Hisinger-Mölkänen Hanna, Backman Helena, Lundbäck Bo, Rönmark Eva, Haahtela Tari, Sovijärvi Anssi, Lehtimäki Lauri, Piirilä Päivi, Kankaanranta Hannu. NSAID-exacerbated respiratory disease: a population study.. ERJ open research. 2022. DOI: 10.1183/23120541.00462-2021.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.